Fiserv earnings missed by $0.61, revenue fell short of estimates
Investing.com - Jefferies has reduced its price target on Accenture plc (NYSE:ACN) to $250.00 from $260.00 while maintaining a Hold rating on the stock. The stock, currently trading at $247, has declined nearly 29% year-to-date, though InvestingPro analysis suggests it may be undervalued at current levels.
The firm cited Accenture’s ongoing restructuring efforts as the company realigns its employee base with its artificial intelligence-focused strategy, a process Jefferies expects to continue for the foreseeable future.
Despite acknowledging Accenture’s solid results and in-line fiscal 2026 guidance, Jefferies believes investor sentiment around AI and its impact on the business will remain the primary near-term driver of the stock.
Jefferies has increased its fiscal 2026 adjusted earnings per share estimate by $0.35 to $13.83 following the company’s latest financial results.
The firm reiterated its Hold rating on Accenture shares, noting that potential upside to the company’s guidance is likely to be modest.
In other recent news, Accenture reported stronger-than-expected fourth-quarter 2025 results, which were followed by guidance for fiscal year 2026 that Mizuho described as "relatively in-line with investor expectations." Despite these results, several firms adjusted their price targets for Accenture. Mizuho lowered its price target from $348 to $309 while maintaining an Outperform rating. Similarly, RBC Capital reduced its target from $372 to $285, citing mixed guidance as a reason. TD Cowen also lowered its price target to $295 from $313, although it reiterated a Buy rating, noting both positive and cautionary factors in Accenture’s outlook. In another development, Accenture has made a strategic investment in Rehuman, a UK-based insurtech startup, to enhance customer engagement in the insurance industry. This investment aims to leverage data and AI technology for more personalized customer experiences. These recent developments provide a multifaceted view of Accenture’s current position and future prospects.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.